Retina Care 360

Study highlights visual and anatomical benefits of faricimab for nAMD

A recent retrospective study evaluated the visual and anatomical outcomes of patients treated with faricimab intravitreal injections (IVI) for neovascular age-related macular degeneration (nAMD). The study included 170 eyes, both previously treated and treatment-naïve. Key Findings: Visual Acuity (VA): Treatment-naïve eyes showed a greater improvement in best-corrected visual acuity (BCVA)...